Download interactions: TXT MITAB-2.5
Interaction | Interactor | Experiments | Homologs | Category | Interaction Score |
Confidence |
---|---|---|---|---|---|---|
RIPL1
RILP-like protein 1 |
2 |
0 |
High-throughput |
0.580 | High |
|
FNDC9
Fibronectin type III domain-containing protein 9 |
2 |
0 |
High-throughput |
0.580 | High |
|
IR3IP
Immediate early response 3-interacting protein 1 |
2 |
0 |
High-throughput |
0.580 | High |
|
TSN
Translin |
1 |
0 |
High-throughput |
0.513 | High |
|
MICA1
[F-actin]-monooxygenase MICAL1 |
1 |
0 |
High-throughput |
0.513 | High |
|
VP33B
Vacuolar protein sorting-associated protein 33B |
1 |
0 |
High-throughput |
0.513 | High |
|
TMPS2
Transmembrane protease serine 2 |
2 |
0 |
High-throughput |
0.316 | High |
|
CD79A
B-cell antigen receptor complex-associated protein alpha chain |
2 |
0 |
High-throughput |
0.316 | High |
|
ATP5J
ATP synthase-coupling factor 6, mitochondrial |
2 |
0 |
High-throughput |
0.316 | High |
|
AR13B
ADP-ribosylation factor-like protein 13B |
2 |
0 |
High-throughput |
0.316 | High |
|
DHB13
17-beta-hydroxysteroid dehydrogenase 13 |
2 |
0 |
High-throughput |
0.316 | High |
|
MILR1
Allergin-1 |
2 |
0 |
High-throughput |
0.316 | High |
|
RETR3
Reticulophagy regulator 3 |
2 |
0 |
High-throughput |
0.316 | High |
|
KASH5
Protein KASH5 |
2 |
0 |
High-throughput |
0.316 | High |
|
GP152
Probable G-protein coupled receptor 152 |
2 |
0 |
High-throughput |
0.316 | High |
|
FATE1
Fetal and adult testis-expressed transcript protein |
2 |
0 |
High-throughput |
0.316 | High |
|
MFF
Mitochondrial fission factor |
2 |
0 |
High-throughput |
0.316 | High |
|
REEP4
Receptor expression-enhancing protein 4 |
2 |
0 |
High-throughput |
0.316 | High |
|
SAR1A
Small COPII coat GTPase SAR1A |
2 |
0 |
High-throughput |
0.316 | High |
|
RNS10
Inactive ribonuclease-like protein 10 |
1 |
0 |
High-throughput |
0.279 | Low |
|
WIPI4
WD repeat domain phosphoinositide-interacting protein 4 |
1 |
0 |
High-throughput |
0.279 | Low |
Service provided by Combinatics, Japan
Last updated: 15 Jul 2024